Status:
UNKNOWN
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Lead Sponsor:
Sheba Medical Center
Conditions:
Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Chronic Progressive
Eligibility:
All Genders
25-65 years
Phase:
PHASE1
Brief Summary
Scientific background: Growing awareness and accumulating data regarding the cognitive impairment and its progression in multiple sclerosis (MS) patients has received an important place in neurologic...
Detailed Description
Scientific background: Growing awareness and accumulating data regarding the cognitive impairment and its progression in multiple sclerosis (MS) patients has received an important place in neurologic...
Eligibility Criteria
Inclusion
- Diagnosis of definite MS according to Poser criteria;
- Attention impairment defined as abnormal PASAT score;
- Written and signed informed consent;
Exclusion
- Pregnancy or lactation;
- Steroid treatment;
- Persistent psychostimulant treatment;
- MS relapse;
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00220493
Start Date
June 1 2003
End Date
June 1 2005
Last Update
January 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Sclerosis Center
Ramat Gan, Israel, 52621